Edwards Lifesciences Corporation Wins $392 Million In Showdown Against Medtronic, Inc.

Edwards Lifesciences Corp. (EW), awarded more than $392 million in a patent-infringement lawsuit against Medtronic Inc. (MDT), plans to ask a judge to prevent its rival from selling a new heart-valve device in the U.S. Medtronic was set to begin selling its CoreValve by April pending Food and Drug Administration clearance, one of the biggest medical-device approvals anticipated by investors this year. Edwards has had the U.S. market to itself for the aortic valves inserted without cracking the chest since November 2011.

Help employers find you! Check out all the jobs and post your resume.